ELI LILLY AND COMPANY LIMITED

Get an alert when ELI LILLY AND COMPANY LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-11-25 (in 6mo)

Last made up 2025-11-11

Watchouts

None on the register

Cash

£151K

-38.6% vs 2023

Net assets

£360M

+3.9% vs 2023

Employees

634

+6.6% vs 2023

Profit before tax

£52M

+60.7% vs 2023

Net assets

2-year trend · vs Health Care median

ELI LILLY AND COMPANY LIMITED·Health Care median · n=826

Accounts

2-year trend · latest reflected 2024-12-31

Metric	2023-12-31	2024-12-31
Turnover	£468,767,000	£889,000,000
Operating profit	£15,208,000	£36,513,000
Profit before tax	£32,212,000	£51,766,000
Net profit	£22,263,000	£38,419,000
Cash	£246,000	£151,000
Total assets less current liabilities	£275,399,000	£300,115,000
Net assets	£346,886,000	£360,288,000
Equity	£346,886,000	£360,288,000
Average employees	595	634
Wages	£64,737,000	£73,431,000

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio	2023-12-31	2024-12-31
Operating margin	3.2%	4.1%
Net margin	4.7%	4.3%
Return on capital employed	5.5%	12.2%
Gearing (liabilities / total assets)	14.2%	35.7%
Current ratio	2.88x	2.03x
Interest cover	2.17x	9.08x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis: FRS 102
Reporting scope: Standalone (parent only)
Auditor: Ernst & Young Chartered Accountants
Audit opinion: Unqualified (clean)
Going concern: Affirmed
“Based upon the directors' knowledge at the date of this report the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the annual report and accounts.”

Group structure

ELI LILLY AND COMPANY LIMITED · parent
1. Lilly Industries Limited 1% · United Kingdom
2. Eli Lilly Leasing Limited 1% · United Kingdom
3. Greenfield Pharmaceuticals Limited 1% · United Kingdom
4. Lilly Research Centre Limited 1% · United Kingdom

Significant events

“On the 14th of October 2024, Eli Lilly and Company announced a strategic collaboration with the Department of Health and Social Care (DHSC), Department for Science, Innovation and Technology (DSIT) and devolved nations to tackle significant population health challenges, including exploring new models to better care for people living with obesity. Lilly anticipates making up to an additional £279 million in new investment into the UK, bringing the expected total Lilly inward investment into the UK up to £435 million.”
“On 21 July 2025 the company declared a dividend for £20,000,000 to be paid on 1 August 2025.”
“On 21 July 2025, the company entered into a Grant Agreement with the Department for Science, Innovation and Technology, and have committed up to £35 million as part of this agreement.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 89 resigned

Name	Role	Appointed	Born	Nationality
ALEXANDER, Karen Ann	Director	2017-08-01	Nov 1967	British
BROAD, Lisa Marie	Director	2022-08-01	Sep 1972	British
STOKES, Christopher J	Director	2024-07-03	Feb 1979	American
WRIGHT, Kristina Mignon	Director	2025-08-08	Nov 1978	American

Show 89 resigned officers

Name	Role	Appointed	Resigned
BENNETT, Hamish John Carmichael	Secretary	2016-05-02	2021-02-11
BURTON, Anya Louise	Secretary	2009-05-01	2011-06-16
BURTON, Anya Louise	Secretary	2007-06-20	2008-09-12
HARPER, Simon Robert	Secretary	2011-06-16	2014-02-01
HARPER, Simon Robert	Secretary	2008-09-12	2009-05-01
HARPER, Simon Robert	Secretary	2006-05-26	2007-06-20
JEPHSON, Wendy Jane	Secretary	2003-03-01	2004-08-25
JEPHSON, Wendy Jane	Secretary	2001-06-30	2002-01-18
OSMAN, Julie	Secretary	2002-01-18	2003-02-28
PEZZACK, Susan Dawn	Secretary	2014-02-01	2016-05-02
UPSHALL, John	Secretary	—	2001-06-30
WORDEN, Timothy James Ashpole	Secretary	2004-08-26	2006-05-26
ADAMSON, Joseph, Dr	Director	1993-12-16	1999-06-30
ASCROFT, Richard Clinton	Director	2009-02-24	2011-11-17
BAILEY, Richard Alan	Director	1994-02-17	1998-06-30
BAILEY, Richard Alan	Director	—	1993-12-16
BENNETT, Hamish John Carmichael	Director	2016-05-02	2021-02-11
BICKLE, Laura Jane	Director	2009-12-21	2011-10-01
BIDOS, Paul	Director	1998-01-01	2001-05-31
BLAIKIE, John Murdoch	Director	—	2000-01-31
BODEM, Barbara Wilson	Director	2006-06-08	2011-06-16
BOTT, Martin	Director	2000-01-31	2003-03-31
BRINER, Karin	Director	2007-09-27	2010-04-01
BROOKS, Douglas Wayne	Director	2014-02-01	2015-03-27
BROWN, James Michael	Director	2011-03-01	2014-02-01
CHATHAM, Sarah Marianna, Dr	Director	2010-04-01	2013-03-01
CHATHAM, Sarah Marianna, Dr	Director	1998-02-19	2004-03-04
CLARK, Alan Stuart	Director	—	1995-11-16
CLARKE, Trafford	Director	2013-03-01	2017-05-31
COSSERY, Jean-Michel Yves, Sylvain	Director	2012-12-18	2016-07-01
COUTTS, Gordon Boyd	Director	1993-12-16	1995-02-16
CZAPAR, Michael	Director	2021-01-01	2023-02-01
DEMAYO STEELE, Laura	Director	2021-07-05	2024-07-03
DIAZ-GRANADOS, Ashley	Director	2018-12-01	2021-07-05
FARRELL, Gerald	Director	2000-02-24	2001-05-31
FLUDZINKI, Pawel	Director	—	1994-11-14
FORDA, Susan Renee, Dr	Director	2017-06-01	2022-08-01
FRY, Stephen Frank	Director	1998-02-19	1999-10-30
GAPINSKI, Darrel Mark	Director	1995-02-16	1998-02-19
GOSS, Rebecca Ann	Director	1994-03-17	1999-02-26
HARPER, Simon Robert	Director	2005-01-04	2014-02-01
HARVEY, Paul Sydney	Director	—	1993-12-16
HAUG, Jonathan Ray	Director	2015-07-16	2018-03-09
HILLIER, Gaynor Jane	Director	2015-03-27	2018-06-30
HIRD, Edward William	Director	1998-01-01	2001-05-31
HOTCHKISS, Andrew Thomas	Director	2003-07-01	2010-01-01
HUMBERT, Melissa	Director	2000-01-31	2002-12-31
HUNTINGTON, Erin Beth	Director	2005-03-01	2008-12-01
INGRAM, Kynon Lamar	Director	2011-10-01	2015-01-27
JOHNSON, Paul	Director	2003-01-01	2007-03-31
KADIM, Yuval	Director	2003-04-01	2006-03-17
KNOWLTON, Ian	Director	1998-01-01	2001-05-31
LEICHT, John George	Director	—	1993-10-21
LEMEN, Nicholas	Director	2018-03-09	2021-01-01
LEWIS, Christopher	Director	2018-07-01	2018-11-30
MANN, Jeremy Marvin	Director	—	1993-12-16
MARTIN, Sabrina Margaret	Director	2007-06-01	2009-10-01
MAYR, Gerhard Nikolaus	Director	—	1997-10-01
MICHAEL, Craig Lee	Director	2006-03-17	2010-02-25
MILLER, Edwin Wayne	Director	1996-08-27	1998-12-31
MOODY, Winton Darin	Director	1999-07-01	2001-07-31
MORISON, Rebecca Anne	Director	2016-07-01	2018-12-01
NICHOLS, Kendall Gordon	Director	2015-01-27	2017-07-31
NONAKA, Yuya	Director	2023-02-01	2025-08-08
PEZZACK, Susan Dawn	Director	2014-02-01	2016-05-02
PEZZACK, Susan Dawn	Director	1998-01-01	2005-01-04
PLUMP, Steven Reed	Director	1997-10-01	1999-07-31
POWELL, Keith Graham	Director	1993-12-16	2003-05-30
POWELL, Rowland	Director	1998-01-01	1999-02-26
PYTYNIA, Thomas Lee	Director	—	1994-03-17
REYNOLDS, Gregory Brian	Director	1995-11-16	1998-02-19
RICE, Derica Will	Director	1999-07-01	2003-06-30
ROBINSON, William John	Director	—	1993-10-21
RUSSELL, John	Director	2000-02-24	2001-05-31
SEDGMAN, Cynthia Anne, Dr	Director	2006-06-08	2008-06-30
SEQUEIRA, Ramona	Director	2010-01-01	2012-12-18
SIMPSON, Alexander, Dr	Director	1995-02-16	2001-05-31
STOKOE, Graham Paul	Director	1993-12-16	1994-11-14
SUN, Emily Meeyoung	Director	2004-03-04	2007-03-31
TAYLOR, Maxine	Director	2000-01-01	2005-03-01
THORP, Thomas Harvey	Director	2011-11-17	2016-12-16
TROUTT, Peter	Director	2010-02-25	2018-11-30
URBANEK, David Alan	Director	2001-08-01	2006-03-17
VAN DEN BERGH, Albertus Joannes Diminicus Maria	Director	1995-11-16	1997-10-01
WHITEHEAD, Stephen	Director	1998-02-19	1999-12-31
WISE, Mark Alan	Director	1993-01-25	1996-08-27
WITZEL, Andreas Franziskus	Director	2003-06-01	2004-06-01
ZINN, Eric Marvin	Director	2011-06-16	2015-07-16
ZUNIGA, Gaspar	Director	2004-06-01	2006-03-24

Ownership

Persons with significant control

Name	Kind	Nature of control	Notified	Status
Eli Lilly Group Limited	Corporate entity	Shares 75–100%, Voting 75–100%, right-to-appoint-and-remove-directors-as-firm, significant-influence-or-control-as-firm	2016-04-06	Active

Filing timeline

Last 20 of 310 total filings

Date	Type	Category	Description
2025-11-17	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2025-09-16	AA	accounts	Accounts with accounts type full
2025-09-03	CH01	officers	Change person director company with change date	PDF
2025-08-14	TM01	officers	Termination director company with name termination date	PDF
2025-08-14	AP01	officers	Appoint person director company with name date	PDF
2024-11-25	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2024-11-22	CH01	officers	Change person director company with change date	PDF
2024-08-24	AA	accounts	Accounts with accounts type full
2024-08-05	CH01	officers	Change person director company with change date	PDF
2024-07-08	AP01	officers	Appoint person director company with name date	PDF
2024-07-05	TM01	officers	Termination director company with name termination date	PDF
2023-11-24	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2023-08-09	AA	accounts	Accounts with accounts type full
2023-02-15	AP01	officers	Appoint person director company with name date	PDF
2023-02-14	TM01	officers	Termination director company with name termination date	PDF
2022-12-21	AP01	officers	Appoint person director company with name date	PDF
2022-12-21	TM01	officers	Termination director company with name termination date	PDF
2022-11-22	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2022-08-31	AA	accounts	Accounts with accounts type full
2021-11-15	CS01	confirmation-statement	Confirmation statement with no updates	PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings: 5
Capital events: 0
Officers appointed: 1
Officers resigned: 1

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Turnover

+89.6%

£468,767,000 £889,000,000
Cash

-38.6%

£246,000 £151,000
Net assets

+3.9%

£346,886,000 £360,288,000
Employees

+6.6%

595 634
Operating profit

+140.1%

£15,208,000 £36,513,000
Profit before tax

+60.7%

£32,212,000 £51,766,000
Wages

+13.4%

£64,737,000 £73,431,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers

Official Companies House page